Discover and read the best of Twitter Threads about #CAC
Most recents (15)
Apostle Joseph Ayodele Babalola - The Story of the Powerful Leader of the Christ Apostolic Church, popularly called CAC in Nigeria
Thread! Retweet
Thread! Retweet
Joseph Ayodele Babalola was born on April 25, 1904 to David Rotimi and Madam Marta Talabi who were members of the Anglican Church. The family lived at Odo-Owa in Ilofa, a small town about ninety kilometres from Ilorin in Kwara State, Nigeria.
His father was the Baba Ijo (literally meaning, father of the church) of the C.M.S. Church at Odo-Owa. According to Pastor Medayese in his book, "Itan Igbe dide Woli Ayo Babalola", mysterious circumstances surrounded the birth of Apostle Babalola. On that day, it was believed
Mercado de Defensivos para trigo cresce 60% em 2022 no Brasil O mercado brasileiro de agrotóxicos para trigo atingiu R$ 2,4 bilhões (US$ 470 bilhões) na safra de inverno de 2022, revelou o estudo anual FarmTrak Trigo, da consultoria Kynetec, ao qual a AgroPages teve acesso em
primeira mão . Entre os inseticidas, conclui, o maior movimento foi para 'pulgões', cerca de 60% ou R$ 134,4 milhões. (1 BRL = 0,20 dólares americanos). A receita registrada na temporada passada representou um aumento de 60% em relação aos R$ 1,5 bilhão do ciclo anterior, em 2021
Segundo a Kynetec, o conflito no Leste Europeu, assim como os problemas climáticos na Argentina e o câmbio favorável às exportações de O Brasil impulsionou a safra de trigo, que exigiu mais insumos. Segundo a FarmTrak, o trigo já é a quinta maior cultura em transações de
1/ #Study #MegaThread
A new study dropped with a trove of data I've long waited for around #CCTA/#CAC scans and #LDL #Cholesterol
✅ >23k studied (!)
✅ Largest sample of CCTA w/ ≥190 #LDL to date (!)
✅ Very uniform study population
Let's unpack...
jamanetwork.com/journals/jaman…
A new study dropped with a trove of data I've long waited for around #CCTA/#CAC scans and #LDL #Cholesterol
✅ >23k studied (!)
✅ Largest sample of CCTA w/ ≥190 #LDL to date (!)
✅ Very uniform study population
Let's unpack...
jamanetwork.com/journals/jaman…
2/ First, be sure to check out this short thread from the lead author, @MaBMortensen.
2 quick notes:
a) While there'll be lots of data appreciated by LDL skepticism, @MaBMortensen maintains LDL-C is still "an important causal RF"
b) Usual epi caveats, etc
2 quick notes:
a) While there'll be lots of data appreciated by LDL skepticism, @MaBMortensen maintains LDL-C is still "an important causal RF"
b) Usual epi caveats, etc
3/ Okay, so if you've followed me a while, you know just how incredibly thankful I am of studies that seek to avoid common risks of selection bias (Even if entirely unintended).
This study had the distinct advantage of categorically scooping its population directly...
This study had the distinct advantage of categorically scooping its population directly...
The NEW @AHAScience @ACCinTouch @ASE360 @accpchest @SAEMonline @Heart_SCCT @SCMRorg Guideline for the Evaluation and Diagnosis of Chest Pain has been released. #CPguideline
jacc.org/doi/10.1016/j.…
Here are highlights for #YesCCT: (1/17)
jacc.org/doi/10.1016/j.…
Here are highlights for #YesCCT: (1/17)
(2/17) #CCTA receives the highest level of recommendation (1A) in new US #CPGuideline
Guideline sponsored by: @AHAScience @ACCinTouch @ASE360 @accpchest @SAEMonline @Heart_SCCT @SCMRorg
In this CP Guideline Tweetorial the (Level of Recommendation is in parentheses).
Guideline sponsored by: @AHAScience @ACCinTouch @ASE360 @accpchest @SAEMonline @Heart_SCCT @SCMRorg
In this CP Guideline Tweetorial the (Level of Recommendation is in parentheses).
(3/17) Acute CP | Intermediate Risk & ⛔known CAD: After ruling out ACS, CCTA is useful to exclude plaque & obstructive CAD as a first line approach (1A) ✅ #CPguideline
Prevalence of Subclinical Coronary Atherosclerosis in General Population
@CircAHA
1/x
🇸🇪 25K randomly invited individuals w/o known CAD underwent CCTA
🇸🇪 51% women
🇸🇪 50 to 64 yrs
🇸🇪 #SCAPIS (the Swedish Cardiopulmonary Bioimage Study)
ahajournals.org/doi/10.1161/CI…
@CircAHA
1/x
🇸🇪 25K randomly invited individuals w/o known CAD underwent CCTA
🇸🇪 51% women
🇸🇪 50 to 64 yrs
🇸🇪 #SCAPIS (the Swedish Cardiopulmonary Bioimage Study)
ahajournals.org/doi/10.1161/CI…
2/x
🇸🇪 42.1% any CCTA-detected atherosclerosis
🇸🇪 5.2% any significant stenosis (≥50%)
🇸🇪 1.9% LM, prox LAD or 3VCAD
🇸🇪 8.3% any non-calcified plaque
🇸🇪 plaques most common in prox LAD
🇸🇪 Participants with only non-Ca plaques were rare (2.4%)
ahajournals.org/doi/10.1161/CI…
🇸🇪 42.1% any CCTA-detected atherosclerosis
🇸🇪 5.2% any significant stenosis (≥50%)
🇸🇪 1.9% LM, prox LAD or 3VCAD
🇸🇪 8.3% any non-calcified plaque
🇸🇪 plaques most common in prox LAD
🇸🇪 Participants with only non-Ca plaques were rare (2.4%)
ahajournals.org/doi/10.1161/CI…
Great session on Artificial Intelligence and Machine learning with session chairs @imagingmedsci, Dr. Bratt, @michael_t_lu, @ivanaisgum, Dr. Al'Aref and @DeCeccoCN at #SCCT2021!
#ICYMI - Here's a brief tweetorial from the #YesCCT session (1/7)
@mirvatalasnag @HeartOTXHeartMD
#ICYMI - Here's a brief tweetorial from the #YesCCT session (1/7)
@mirvatalasnag @HeartOTXHeartMD
#AI & ML in #YesCCT: #SCCT2021 #Tweetorial (2/7)
1⃣: The big picture & black box by Dr. Michael Lu
-Multiple “black box” definitions
-Explainability
-Predictability
-More accurate than SOC, visualizes output (& modifiable), communicates uncertainty (eg grey-zone FFR-CT)
1⃣: The big picture & black box by Dr. Michael Lu
-Multiple “black box” definitions
-Explainability
-Predictability
-More accurate than SOC, visualizes output (& modifiable), communicates uncertainty (eg grey-zone FFR-CT)
3⃣#AI & ML in #YesCCT #SCCT2021: New frontiers in atherosclerosis @AChoiHeart
-Use of #CNN for whole heart stenosis & atherosclerosis
-Improved reproducibility of stenosis to enhance guideline adherence
-Individualized risk prediction
-New Rx paradigm!
-Use of #CNN for whole heart stenosis & atherosclerosis
-Improved reproducibility of stenosis to enhance guideline adherence
-Individualized risk prediction
-New Rx paradigm!
Women are not smaller men! #Atherosclerosis genesis, progression & sequelae different in women. Plaque erosion causing ACS more common in women. Women have unique #SDOH, are undertreated with #cvPrev therapies & #GDMT, leads to worsening outcomes in women. @lesleejshaw #SCCT2021
Women’s CVD risk can be underestimated. Female specific risk enhancers help. #CAC if risk uncertain. Women have lower #CAC prevalence than men but prevalence increases after menopause. CAC when present confers greater risk of incident CVD in women than men. @lesleejshaw #SCCT2021
Prevalence of non-obstructive #CAD is higher in women but is prognostic of risk. @lesleejshaw #SCCT2021
Top 10 paper in #yesCCT by @ToddVillinesMD
1st paper
📝 Italian COVID 19 registry
N=1625
📝 Increasing #CAC associated with worse covid 19 outcomes of hospital death, MI and CVA
#YesCCT
1st paper
📝 Italian COVID 19 registry
N=1625
📝 Increasing #CAC associated with worse covid 19 outcomes of hospital death, MI and CVA
#YesCCT
2nd paper #Top10 papers #yesCCT
#SCCT2021
danish heart registry
📝 Plaque burden, not stenosis the main predictor of MACE
📝 patients with a comparable calcified atherosclerosis burden generally carry a similar risk for CVD events
jacc.org/doi/abs/10.101…
#SCCT2021
danish heart registry
📝 Plaque burden, not stenosis the main predictor of MACE
📝 patients with a comparable calcified atherosclerosis burden generally carry a similar risk for CVD events
jacc.org/doi/abs/10.101…
3rd paper #Top10 papers #yesCCT
#SCCT2021
CREDENCE trial
📝 Stress MPI vs #yesCCT for diagnosis of coronary physiology
📝 #yesCCT superior to stress MPI in the diagnosis of invasive FFR
jamanetwork.com/journals/jamac…
@lesleejshaw @RonBlankstein @AChoiHeart @ghoshhajra
#SCCT2021
CREDENCE trial
📝 Stress MPI vs #yesCCT for diagnosis of coronary physiology
📝 #yesCCT superior to stress MPI in the diagnosis of invasive FFR
jamanetwork.com/journals/jamac…
@lesleejshaw @RonBlankstein @AChoiHeart @ghoshhajra
We are at the point in the Climate Action Committee CAC where departments try to put the put the public to sleep so we won't notice what their recommendations are. Looking at you, @NYSDOT! #CLCPA
People, we are in BIG trouble. The @NYSDOT commissioner says this "after" photo perfectly illustrates "smart growth." A huge, useless median simply does not facilitate more walking, biking, transit, all the things we need to reduce VMT in New York State. What is going on?!?!
Hairpulling now commencing: Commissioner is calling Uber, Lyft, and Via "micromobility." How is this possible? At this stage in the game and with this much at stake? #ClimateActionCouncil @NYSDOT, you simply MUST do better. @NYGovCuomo
Attending virtual #SCCT2020 today?
Interested in #CAD, #CAC, #coronary plaque?
All you need to do is to tune into channel 1 in morning & channel 2 in afternoon to learn from experts & ask your Qs
Here are morning sessions on Channel 1 👇
tinyurl.com/yccr8t4k
Interested in #CAD, #CAC, #coronary plaque?
All you need to do is to tune into channel 1 in morning & channel 2 in afternoon to learn from experts & ask your Qs
Here are morning sessions on Channel 1 👇
tinyurl.com/yccr8t4k
& here are #SCCT2020 early afternoon sessions on Channel 2 for #coronary enthusiasts 👇
tinyurl.com/yccr8t4k
tinyurl.com/yccr8t4k
& finally #SCCT2020 late afternoon sessions on Channel 2 for #coronary enthusiasts 👇
tinyurl.com/yccr8t4k
tinyurl.com/yccr8t4k
Join us now for this case-based education session from @HMethodistCV by @almallahmo & John Mahmarian
#ASNC2019 #CVnuc
#ASNC2019 #CVnuc
What is your approach to a pre-op asx patient with nl perfusion but #CAC 3,400 on SPECT?
@khurramn1 @venkmurthy @RonBlankstein @almallahmo
#ASNC2019
@khurramn1 @venkmurthy @RonBlankstein @almallahmo
#ASNC2019
⚡️ #YesCCT Coronary Plaque Assessment #Tweetorial ⚡️
By @CoronaryDoc + @AChoiHeart
✅ Why Plaque Assessment?
✅ High Risk Plaque Features
✅ Plaque Characterization/Quantification
✅ Supporting Clinical Data
#CardioTwitter #ACCImaging #SCCT2019 @heart_scct @journalCCT
1/14
By @CoronaryDoc + @AChoiHeart
✅ Why Plaque Assessment?
✅ High Risk Plaque Features
✅ Plaque Characterization/Quantification
✅ Supporting Clinical Data
#CardioTwitter #ACCImaging #SCCT2019 @heart_scct @journalCCT
1/14
2/14
As #SCD or #MI is 1st symptom of #atherosclerosis in 2/3 of pts, early ID of #CAD is of paramount importance
#YesCCT allows for
✅ ID of plaque
✅ Quant. of plaque
✅ Characterization of plaque
✅ Arterial remodeling
Lin, @LubbDup & @lesleejshaw: bit.ly/2x1b5Yz
As #SCD or #MI is 1st symptom of #atherosclerosis in 2/3 of pts, early ID of #CAD is of paramount importance
#YesCCT allows for
✅ ID of plaque
✅ Quant. of plaque
✅ Characterization of plaque
✅ Arterial remodeling
Lin, @LubbDup & @lesleejshaw: bit.ly/2x1b5Yz
3/14
Serial angiographic studies have demonstrated an accelerated & rapid plaque progression before most cases of ACS
Rapid plaque growth ➡️ plaque rupture ➡️ thrombus formation ➡️ MI
@LubbDup & @JonathonLeipsic et al: bit.ly/2WIt5Bj
Serial angiographic studies have demonstrated an accelerated & rapid plaque progression before most cases of ACS
Rapid plaque growth ➡️ plaque rupture ➡️ thrombus formation ➡️ MI
@LubbDup & @JonathonLeipsic et al: bit.ly/2WIt5Bj
✅ Do we have enough evidence to use #CAC zero in pts with stable angina?
✅ What about pts with new Dx of #HF? What’s probability of ischemic cardiomyopathy (obs #CAD) with #CAC zero?
@Heart_SCCT @khurramn1 @MichaelJBlaha @RonBlankstein @lesleejshaw
bit.ly/2IscVbS
✅ What about pts with new Dx of #HF? What’s probability of ischemic cardiomyopathy (obs #CAD) with #CAC zero?
@Heart_SCCT @khurramn1 @MichaelJBlaha @RonBlankstein @lesleejshaw
bit.ly/2IscVbS
@AChoiHeart @DrRumberger @FiRSTSCCT @MarcDweck @joshmitchellmd @SuhnyAbbara @jameschilee @jeffreygeske @arnavkumar @Fentanes_MD @ErinMichos @HeartOTXHeartMD @gina_lundberg @purviparwani @onco_cardiology @RBP0612 @mdmiedema @DrRyanPDaly @mmamas1973 @DrMarthaGulati
@ghoshhajra
@ghoshhajra
Let’s discuss this @Open_HeartBMJ paper
1/3
✅ 1753 pts with suspected stable angina, no known CAD, from a hospital in UK (2009-2016)
✅ CCTA in 751 pts (52%) with #CAC zero showed
▪️89.7% normal coronaries
▪️8.4% stenosis <50%
▪️1.9% stenosis >50%
bit.ly/2IscVbS
1/3
✅ 1753 pts with suspected stable angina, no known CAD, from a hospital in UK (2009-2016)
✅ CCTA in 751 pts (52%) with #CAC zero showed
▪️89.7% normal coronaries
▪️8.4% stenosis <50%
▪️1.9% stenosis >50%
bit.ly/2IscVbS
Intro to #CAC Tweetorial!
For #ACCFIT, @FiRSTSCCT @ACRRFS #ACCImaging,
@heart_scct #YesCCT #AHA18 #SCCT2019 #Cardiotwitter 😀😀
*⃣Case
*⃣Basics on CAC
*⃣CAC & prognosis
*⃣ACC/AHA 2018 vs SCCT 2017 guidelines
*⃣Case follow-up
(1/n)
For #ACCFIT, @FiRSTSCCT @ACRRFS #ACCImaging,
@heart_scct #YesCCT #AHA18 #SCCT2019 #Cardiotwitter 😀😀
*⃣Case
*⃣Basics on CAC
*⃣CAC & prognosis
*⃣ACC/AHA 2018 vs SCCT 2017 guidelines
*⃣Case follow-up
(1/n)
Here’s a case – similar to patients we see everyday in the primary care and cardiology offices. (2/n)
72 year-old asymptomatic healthy 💃
BP 117/74, BMI 22
Lipids: TC 270, TG 100 HDL 90 LDL 155
ACC/AHA ASCVD Risk: 10%
#AHA2018 #YesCCT #CAC #ACCImaging
72 year-old asymptomatic healthy 💃
BP 117/74, BMI 22
Lipids: TC 270, TG 100 HDL 90 LDL 155
ACC/AHA ASCVD Risk: 10%
#AHA2018 #YesCCT #CAC #ACCImaging
POLL:
Based on the clinical information, would you (3/n):
#AHA2018 #YesCCT #CAC #SCCT2019 #ACCImaging #Cardiotwitter
Based on the clinical information, would you (3/n):
#AHA2018 #YesCCT #CAC #SCCT2019 #ACCImaging #Cardiotwitter
No benefit from #statins in patients with a #CAC score of zero
#ThePowerOfZero by #YesCCT shown again @JACCJournals by @lesleejshaw
@Heart_SCCT @AChoiHeart @khurramn1 @ghoshhajra
@MichaelJBlaha @RonBlankstein @ErinMichos @DrMarthaGulati @gina_lundberg @ChinnaiyanMD
#ThePowerOfZero by #YesCCT shown again @JACCJournals by @lesleejshaw
@Heart_SCCT @AChoiHeart @khurramn1 @ghoshhajra
@MichaelJBlaha @RonBlankstein @ErinMichos @DrMarthaGulati @gina_lundberg @ChinnaiyanMD
Big win for #CAC in 2018 Cholesterol Guidelines just published @CircAHA
#CAC is now recommended for risk reclassification in low & intermediate risk patients to guide decision making for statin therapy
ahajournals.org/doi/10.1161/CI…
@AHAMeetings @MichaelJBlaha @ASPCardio @AHAScience
#CAC is now recommended for risk reclassification in low & intermediate risk patients to guide decision making for statin therapy
ahajournals.org/doi/10.1161/CI…
@AHAMeetings @MichaelJBlaha @ASPCardio @AHAScience
